Sugar molecules as a physical barrier separating therapeutic antibody proteins in freeze-dried formulations: small-angle X-ray scattering insights

Abstract The paper investigates structure of freeze-dried formulations of a therapeutical monoclonal IgG 1 with non-reducing disaccharides, sucrose and trehalose, as lyoprotectors. Formulations with variable sugar-to-protein ratios are manufactured using different freeze-drying protocols and post-drying temperature treatments. Small-angle X-ray scattering (SAXS) is applied to study packing arrangements of IgG 1 molecules in the crowded solid-state environment. The retention of amorphous structure by the lyoprotectors is confirmed with the simultaneous wide-angle X-ray scattering (WAXS) tests. The new finding is the observation of two IgG 1 SAXS peaks in the crowded environment, with position of one peak (peak A) changing with sugar-to-protein ratio, whereas the second peak (peak B) position is similar in all the formulations tested. The protein center of mass distance, which is calculated from the position of the peak A, increases with the increase in sugar content from 45 Å to 65 Å (sugar-to-protein mass ratio 0.79 to 7.95). Sugar molecules therefore serve as a physical barrier between IgG 1 molecules. While the sugar-to-protein ratio significantly impacts protein separation, other factors, such as disaccharide type, presence of a surfactant, or drying process and post-drying thermal treatment, have minimal effect. The origin of the peak B has not been established yet, with three hypotheses considered. The results highlight applicability of SAXS for quantification of separation distances between protein molecules in freeze-dried formulations, thus improving the fundamental understanding of the stability of protein drugs. Graphical Abstract

Authors

Institutions

Publication Details

Journal
AAPS Open
Published
2025-09-29
DOI
https://doi.org/10.1186/s41120-025-00120-8
Primary Topic
Protein purification and stability
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sugar molecules as a physical barrier separating therapeutic antibody proteins in freeze-dried formulations: small-angle X-ray scattering insights

R. Nagel, Sebastian Groël, Wolfgang Frieß, Jonas Binder et al.
AAPS Open
Protein purification and stability
article

Sugar molecules as a physical barrier separating therapeutic antibody proteins in freeze-dried formulations: small-angle X-ray scattering insights

R. Nagel, Sebastian Groël, Wolfgang Frieß, Jonas Binder, Michael Sztucki, Tim Menzen, Evgenyi Shalaev, Gerhard Winter
article en

Abstract

Abstract The paper investigates structure of freeze-dried formulations of a therapeutical monoclonal IgG 1 with non-reducing disaccharides, sucrose and trehalose, as lyoprotectors. Formulations with variable sugar-to-protein ratios are manufactured using different freeze-drying protocols and post-drying temperature treatments. Small-angle X-ray scattering (SAXS) is applied to study packing arrangements of IgG 1 molecules in the crowded solid-state environment. The retention of amorphous structure by the lyoprotectors is confirmed with the simultaneous wide-angle X-ray scattering (WAXS) tests. The new finding is the observation of two IgG 1 SAXS peaks in the crowded environment, with position of one peak (peak A) changing with sugar-to-protein ratio, whereas the second peak (peak B) position is similar in all the formulations tested. The protein center of mass distance, which is calculated from the position of the peak A, increases with the increase in sugar content from 45 Å to 65 Å (sugar-to-protein mass ratio 0.79 to 7.95). Sugar molecules therefore serve as a physical barrier between IgG 1 molecules. While the sugar-to-protein ratio significantly impacts protein separation, other factors, such as disaccharide type, presence of a surfactant, or drying process and post-drying thermal treatment, have minimal effect. The origin of the peak B has not been established yet, with three hypotheses considered. The results highlight applicability of SAXS for quantification of separation distances between protein molecules in freeze-dried formulations, thus improving the fundamental understanding of the stability of protein drugs. Graphical Abstract

AAPS OpenVol. 11(1)
European Synchrotron Radiation Facility (FR), AbbVie (United States) (US), Max Planck Institute of Neurobiology (DE), Ludwig-Maximilians-Universität München (DE)
European Synchrotron Radiation Facility
Openalex Percentile: Top 76%
Protein purification and stability
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.